| Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein AC Walls, YJ Park, MA Tortorici, A Wall, AT McGuire, D Veesler Cell 181 (2), 281-292. e6, 2020 | 7028 | 2020 |
| Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ... Nature 583 (7815), 290-295, 2020 | 1136 | 2020 |
| Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding TN Starr, AJ Greaney, SK Hilton, D Ellis, KHD Crawford, AS Dingens, ... Cell 182 (5), 1295-1310. e20, 2020 | 1091 | 2020 |
| Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ... Cell 183 (4), 1024-1042. e21, 2020 | 691 | 2020 |
| Unexpected receptor functional mimicry elucidates activation of coronavirus fusion AC Walls, X Xiong, YJ Park, MA Tortorici, J Snijder, J Quispe, E Cameroni, ... Cell 176 (5), 1026-1039. e15, 2019 | 488 | 2019 |
| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell 184 (9), 2332-2347. e16, 2021 | 446 | 2021 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 444 | 2021 |
| Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer AC Walls, MA Tortorici, BJ Bosch, B Frenz, PJM Rottier, F DiMaio, FA Rey, ... Nature 531 (7592), 114-117, 2016 | 437 | 2016 |
| Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion AC Walls, MA Tortorici, J Snijder, X Xiong, BJ Bosch, FA Rey, D Veesler Proceedings of the National Academy of Sciences 114 (42), 11157-11162, 2017 | 434 | 2017 |
| Structural basis for human coronavirus attachment to sialic acid receptors MA Tortorici, AC Walls, Y Lang, C Wang, Z Li, D Koerhuis, GJ Boons, ... Nature structural & molecular biology 26 (6), 481-489, 2019 | 423 | 2019 |
| Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 324 | 2022 |
| Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 EB Hodcroft, M Zuber, S Nadeau, TG Vaughan, KHD Crawford, ... Nature 595 (7869), 707-712, 2021 | 314 | 2021 |
| SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern M McCallum, J Bassi, A De Marco, A Chen, AC Walls, J Di Iulio, ... Science 373 (6555), 648-654, 2021 | 300 | 2021 |
| Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy AC Walls, MA Tortorici, B Frenz, J Snijder, W Li, FA Rey, F DiMaio, ... Nature structural & molecular biology 23 (10), 899-905, 2016 | 300 | 2016 |
| De novo design of picomolar SARS-CoV-2 miniprotein inhibitors L Cao, I Goreshnik, B Coventry, JB Case, L Miller, L Kozodoy, RE Chen, ... Science 370 (6515), 426-431, 2020 | 275 | 2020 |
| Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ... Cell 183 (5), 1367-1382. e17, 2020 | 238 | 2020 |
| Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors YJ Park, AC Walls, Z Wang, MM Sauer, W Li, MA Tortorici, BJ Bosch, ... Nature structural & molecular biology 26 (12), 1151-1157, 2019 | 189 | 2019 |
| SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park, A Addetia, D Pinto, ... Nature 597 (7874), 97-102, 2021 | 130 | 2021 |
| Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections X Xiong, MA Tortorici, J Snijder, C Yoshioka, AC Walls, W Li, AT McGuire, ... Journal of virology 92 (4), e01628-17, 2018 | 115 | 2018 |
| An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates JH Erasmus, AP Khandhar, MA O’Connor, AC Walls, EA Hemann, ... Science translational medicine 12 (555), eabc9396, 2020 | 106 | 2020 |
David VeeslerUniversity of WashingtonVerified email at uw.edu
